Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 592-597 , November 2009

Prognostic significance of prostate cancer originating from the transition zone

  • Christopher R. King, Ph.D., M.D.

      Affiliations

    • Department of Radiation Oncology, Division of Urologic Oncology; Stanford University School of Medicine, Stanford, CA 94305, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-650-736-0698; fax: +1-650-725-8231
    • ,
  • Michelle Ferrari, R.N.

      Affiliations

    • Department of Urology, Division of Urologic Oncology; Stanford University School of Medicine, Stanford, CA 94305, USA
    • ,
  • James D. Brooks, M.D.

      Affiliations

    • Department of Urology, Division of Urologic Oncology; Stanford University School of Medicine, Stanford, CA 94305, USA

Received 24 March 2008 ,Revised 16 May 2008 ,Accepted 23 May 2008.

References 

  1. Noguchi M, Stamey TA, McNeal JE, et al. An analysis of 148 consecutive transitional zone cancers: Clinical and histological characteristics. J Urol. 2000;163:1751–1755
  2. McNeal JE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma (Correlation with histological pattern and direction of spread). Am J Surg Pathol. 1988;12:897–906
  3. McNeal JE. Cancer volume and site of origin of adenocarcinoma of the prostate: Relationship to local and distant spread. Hum Pathol. 1992;23:258–266
  4. Greene DR, Wheeler TM, Egawa S, et al. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol. 1991;146:1069–1076
  5. Stamey TA, Dietrick DD, Issa MM. Large, organ confined impalpable transition zone prostate cancer: Association with metastatic levels of prostate specific antigen. J Urol. 1993;149:510–515
  6. Steuber T, Karakiewicz PI, Augustin H, et al. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions. J Urol. 2005;173:737–741
  7. Presti JC, O'Dowd GJ, Miller MC, et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: Results of a community multi-practice study. J Urol. 2003;169:125–129
  8. Meng MV, Franks JH, Presti JC, et al. The utility of apical anterior horn biopsies in prostate cancer detection. Urol Oncol. 2003;21:361–365
  9. Beahrs OH, Hensen DE, Hutter RV, et al. AJCC Cancer Staging Manual. In: 4th edition. Philadelphia (PA): J. B. Lippincott; 1992;p. 181–186
  10. Gleason DF. Histologic grading and clinical staging of prostate carcinoma. In:  Tannenbaum M editors. Urologic Pathology: The Prostate. Philadelphia (PA): Lea and Febiger; 1977;p. 171–197
  11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;3:457–500
  12. D'Amico AV, Chen M-H, Roehl KA, et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004;351:121–135
  13. Patel D, Presti JC, McNeal JE, et al. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. J Clin Oncol. 2005;23:6157–6162
  14. Stamey TA, McNeal JE, Yemoto CM, et al. Biological determinants of cancer progression in men with prostate cancer. JAMA. 1999;281:1395–1400
  15. Albertsen PC, Hanley JA, Barrows GH, et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst. 2005;97:1248–1253
  16. Augustin H, Erbersdobler A, Graefen M, et al. Biochemical recurrence following radical prostatectomy: A comparison between prostate cancers located in different anatomical zones. The Prostate. 2003;55:48–54
  17. Augustin H, Hammerer PG, Blonski J, et al. Zonal location of prostate cancer: Significance for disease-free survival after radical prostatectomy?. Urology. 2003;62:79–85

☆ This research was supported in part by grants to J.D.B. from the National Institutes of Health grant CA111782, Stanford University Bio-X Interdisciplinary Initiatives Award and the Canary Foundation.

PII: S1078-1439(08)00123-3

doi: 10.1016/j.urolonc.2008.05.009

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 6 , Pages 592-597 , November 2009

Article Tools

* Image Usage & Resolution